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Parasiticides have been the most valuable weapons to combat parasites for almost half a 
century, constituting more than 50 % of veterinary pharmaceuticals and a good part of the 
products destined for human health. However, in many parts of the world, parasites develop 
resistance to these drugs, and it is now a major health problem. One way to avoid this in-
convenience is the in-depth knowledge of its mechanisms of action, which will allow a 
more appropriate use. This work is a review of the different physiological aspects of parasi-
te species and an explanation of the different mechanisms of action of antiparasitic agents. 
Once these drugs are ingested or absorbed by parasites the agents come into contact 
with the parasites structures, and according to the drug's properties it will define the antipa-
rasitic activity either by altering tegument, carbohydrates, protein and lipid metabolism, or 
motility of the multicellular parasites. 
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The grand revolution on biochemistry during the last half of the twentieth 
century opened new fields of research for the development of selective parasitic 
agents (Mansour, 2002). In general, drugs can exert antiparasitic activity by al-
tering tegument, carbohydrates, protein and lipid metabolism, and motility (Di 
Genova, 2016) (fig.1). The gene-expression machinery has been among the first 
targets for antiparasitic drugs and is still under investigation as a target for novel 
compounds. Other targets include cytoskeletal proteins, proteins involved in int-
racellular signaling, membranes, and enzymes participating in intermediary me-
tabolism. In apicomplexan parasites, the apicoplast is a suitable target for estab-
lished and novel drugs (Müller, Hemphill, 2013). Some drugs act on multiple 
sub-cellular targets. Drugs with nitro groups generate free radicals under ana-
erobic growth conditions, and drugs with peroxide groups generate radicals un-
der aerobic growth conditions, both affecting multiple cellular pathways. Mef-
loquine and thiazolides are presented as examples for antiprotozoan compounds 
with multiple side effects (Müller, Hemphill, 2013). Regardless of the mode of 
Fig. 1. Physiology of the parasite and potential sites of therapeutic intervention. In this figure we can 
identify at least 10 site where drugs may potentially exert their effects. 
POSSIBLE TARGETS OF ANTIPARASITIC DRUGS 
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action, antiparasitic drugs must be ingested or absorbed by intestinal worms for 
expulsion of the parasite from the host. Most intestinal nematodes ingest materi-
al by pharyngeal pumping, which is altered by exogenous biological amines in 
both free and zooparasitic species (Abbott, 2004). Unfortunately, anthelmintics 
that cause neuromuscular paralysis may inhibit their own uptake by the exposed 
parasite by depressing this pumping (Martin, 2010). 
Though the ability of a drug to cross the parasite's tegument it was always 
considered a major point to increase its efficacy, Some studies (Shah, 1983) de-
monstrated that the penetration of carbaryl, dichlorodiphenyltrichloroethane 
-DDT-, dieldrin and permethrin in insects and parasites is neither rapid nor se-
lective. Thus effectiveness of a drug may depend on its metabolism, storage and 
transport, more than on its penetration ability. Other authors, however, do not 
agree since liposolubility of organic chlorides favours penetration and efficacy 
of organic phosphates (Burgat, Sacaze, 1988). Albendazole reaches higher con-
centrations than its oxidized metabolites (sulfoxide and sulphone) in Fasciola 
hepatica because the original drug is more liposoluble (Fetter, 1984). 
Other studies suggest that penetration and possibility of reaching receptors 
influence efficacy, although the susceptibility of the parasite should not be igno-
red. In this way pyrantel would exert little effect on Trichuris spp. because of a 
lack of penetration, although the susceptibility of the parasite should not be ig-
nored (Terada et al., 1983a). It seems almost certain that penetration, distribu-
tion, metabolism and elimination are key issues to obtain best effects from an 
antiparasitic drug. A more selective mechanism of action has been proposed re-
cently for these agents based om the effect on the tegument of cercarias — 
Schistosoma mansoni, tegument changes similar to those produced when larvae 
penetrate through the skin could be induced. If larvae do not penetrate, they die, 
because of their osmotic susceptibility to water. This action could be produced 
by substances like 2-tetradecenoic acid that are only slightly toxic to other aqua-
tic organisms (Haas, 1984). 
The induction of abnormal activity in parasites' alimentary and/or reproduc-
tive habits could lead to lethal or sublethal effects. Some drugs can induce ano-
rexia, like the thiolic oxidant etilendiamide in Triatoma infestans, apparently by 
sulphydril (SH) groups reacting with abdominal receptors and probably modify-
ing CNS neurotransmission. 
Formamidines can produce a similar action in insects, mites and ticks (Ho-
lingworth, 1976; Hollingworth, Murdock, 1980; Giordani et al., 1986). Changes 
in alimentary habits of ticks are induced by drugs altering pheromone produc-
tion (2, 6 dichlorophenol in the majority of tick genera studied). This phero-
mone would affect sexual attraction, migration and feeding (Gothe, 1983). 
In insects and ticks, ecdisteroids play an important role in growth and deve-
lopment. Arthropods are able to esterify these substances into long chain fatty 
acids, probably inactivating excessive amounts ingested with the hervibore 
host's blood (Diehll et al., 1985). A change in ecdisteroids metabolism would be 
a possible target in the arthropods. 
A new group of 1, 5 di-sustituted imidazoles (1 citronelil-5-fenilimidazol) 
(Kuwano et al., 1984; Kuwano et al., 1985) antagonize synthesis of juvenile 
hormones in insect larvae (Lepidoptera: Bombix mori) favouring precox meta-
morphosis. Some of the drugs have also anorexic properties perhaps providing a 
new path to attack insects (Asano et al., 1984). 
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Regarding carbohydrate metabolism, available information is based on «in 
vitro» helminth research. For a better understanding of differences of drug acti-
ons in different species, changes in glucose metabolism in nematodes, tremato-
des and cestodes must be considered (fig. 1). There are no differences in gluco-
lysis until phosphoenolpyruvate (PEP) is produced (Berg, 2002). Nematodes 
(Ascaris suum) transform most PEP into oxalacetate (OAA). Then, OAA is 
transformed in mitochondrial membranes into pyruvate and fumarate and this 
last into succinate (Fairbarn, 1961; Berg, 2002) through fumarate reductase 
(FR). The formation of adenosine triphosphate is associated with this reaction. 
Nematodes thus depend largely on their mitochondrial cycle to obtain energy, 
although there are some differences among them. For example Litosomoides ca-
rinii, unlike Ascaris spp. and some other helminths, can produce ATP in mito-
chondria in the presence of succinate and pyruvate, plus malate, using also oxy-
gen (Ramp et al., 1985). On the other hand, in Ascaris spp., fumarate plays the 
role of oxygen in an aerobic system (Rew, 1978). Brugia pahangi and Dipetalo-
nema vitae also use oxygen, as demonstrated by the diminution of ATP produc-
tion when oxygen is lacking (Mendis et al., 1985). 
Cestodes convert PEP 50 % in pyruvate and 50 % in OAA (fig. 1) which is 
then converted to malate, malate is used as in Ascaris spp. to obtain ATP in the 
mitochondria (Bueding, Saz, 1968). 
Trematodes transform PEP into final products like pyruvate and lactate. This 
would not involve mitochondria, although Isseroff and Walczac (1971) found 
succinate excretion by Fasciola hepatica (fig. 2). 
Some larval stages, like oncosferas, appear inactive metabolically and would 
not be susceptible to drugs that interfere with metabolism (Siracusano, 2009). 
This is true also for some helminth larvae, like Ostertagia ostertagii, although 
in this case, efficacy of active drugs seems to increase when there is long expo-
sure of larvae to the drug as with reduced drug solubility, passage of low amo-
unts of drugs from rumen to abomasum, and persistence of abomasal concentra-
tions for several days (Armour, 1986). 
As in vertebrates (Abou-Donia, Womeir, 1986), differences in susceptibility 
of different ages parasites to drugs would probably be due to differing activities 
of enzyme systems. 
Protein metabolism and nucleic acid synthesis can be altered by drugs. The 
antitrypanosomal agents berenyl, antricyde and suramine, block incorporation 
of aminoacids (AA) into parasite proteins (Smith, 2009). Benznidazol, used to 
treat Chagas disease is South America, binds covalently to proteins and nucleic 
acids, altering them (Trochine, 2014). Microtubules, as essential components of 
almost all eukaryotic cells, are proven drug targets in many helminth diseases 
and show promise as targets for the development of new antiprotozoal drugs 
(Fennell et al., 2008). 
Little is known about lipid metabolism in parasites and possible ways to mo-
dify it. Cholesterol is necessary for development of Ascaris larvae (Fleming, 
Fetterer, 1983), and is obtained by transcuticular transport. This transport is also 
used by glucose and some anthelmintics (Verhoeven et al., 1976). 
Early farmers used seaweed as a natural pesticide to protect plants and live-
stock but the reason why seaweed was an effective pesticide was unclear. More 
recently, studies have shown that betaine, an amino acid that functions as an os-
molyte and methyl donor, which is present in seaweed, arrests nematode larval 
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Fig. 2 Metabolic pathways. In this figure we can see the metabolic pathways follow up by the princi-
pals helmints. 
development, but the molecular target and pathway for its effect still remained 
unknownBetaine transporter SNF-3 and betaine receptor ACR-23 were found in 
the nematode C. elegans overactivation of the receptor by excess betaine or by 
the allosteric modulator monepantel resulted in hypercontraction and death of 
the nematode (Zhen, 2017). Thus, monepantel targets a betaine signaling path-
way in nematodes (Peden et al., 2013). 
So, as mentioned above, antiparasitic agents use parasite components as site 
of union to do their jobs. Now, let's take a deeper look at the inside of each 
group. 
1. IMIDAZOL DERIVATIVES 
Imidazoles were a breakthrough in antiparasitic treatment. A N substitution 
of imidazoles created the family of triazoles, which have the same mechanism 
of action as imidazoles, similar or broader spectrum, but with less effect on the 
synthesis of human sterols (see table). 
1 . 1 . B e n z o i m i d a z o l e s (BIZ) 
The BIZ are used to treat nematode and trematode infections in humans and 
animals. It acts by binding to the microtubules. It also binds to the spindle mic-
rotubules and blocks nuclear division (Loukas, Hotez, 2006; Lutz, 2012). 
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Imidazole derivatives used as veterinary anthelmintics1 
Group Drugs 
Benzoimidazole (BIZ) Thiabendazole (TBZ) 
derivatives 
Benzoimidazole carbamates Albendazole (ABZ), Mebendazole (MBZ), Fenbendazole 
(BIZ-C) (FBZ), Cambendazole (CBZ), Oxfendazole (OXZ), 
Oxibendazole (OxiZ), Flubendazole (FluBZ), Lobendazole 
(LBZ), Triclabendazole (TriBZ), Luxabendazole (LuxBZ), 
Ricobendazole (RBZ) 
Pro-benzoimidazole (pro BIZ) Febantel, Netobimin, and Tiofanato 
Nitroimidazole (NIZ) Benznidazole, metronidazole, dimetridazole, tinidazole 
derivatives 
Imidazol phenolic complex Clotrimazole, miconazole, ketoconazole 
derivatives 
Imidazotiazols Levamisole, Tetramisole 
Note. 1 In this table we can observe the differents groups with antiparasitic activity and also the me-
dicines that makes up each group. 
The first veterinary BIZ introduced in the 1960's (e. g. Thiabendazole — 
TBZ, Oxfendazole — OXZ) were highly effective against adults and larvae 
of most gastrointestinal roundworms (nematodes) of livestock. In the 1970's 
newer benzimidazoles such as albendazole, fenbendazole, mebendazole and ox-
fendazole were introduced that are also effective against non-gastrointestinal ro-
undworms (in the lungs, kidneys, skin, etc., depending on compound and dose) 
as well as against tapeworms (cestodes). Albendazole is also effective against 
adult liver flukes (Fasciola hepatica). TBZ is a special case: it is not effective 
against roundworms or tapeworms, but controls all larval and adult stages ofva-
rious parasitic liver flukes (trematodes) (Junquera, 2015). 
TBZ represented a major step forward when it became available more than 
30 years ago. At that moment; it was a novel, true broad-spectrum and potent 
anthelmintic with a classic mechanism of action and safe for the animal. Since 
that time parasite resistance to the BIZ has been discovered in several species 
(Bowman, 2014). From TBZ, by a series of substitutions, different Benzoimida-
zole carbamates -BIZ-C were obtained. These have a carbamate group that inc-
reases the anthelmintic effect through a second mechanism. Pro-BIZ com-
pounds, like febantel are biotransformed into BIZ, and act similar to this last 
(Deitsch, 2001). 
TBZ and most BIZ-C except Mebendazole -MBZ, inhibit mitochondrial FR 
«in vitro», especially in nematodes (Robetson, 1982). Consequently succinate 
and ATP, cannot be produced. This is a slow process, and parasite elimination 
takes some 2—3 days after treatment (Shang, 1981). 
Another site of action was suggested to explain the wide spectrum of these 
drugs including fourth-stage larvae (L4) inhibited stages of Ostertagia spp. 
(Williams, 1991). This also depends on drug concentration and, possibly more 
importantly, the duration of drug exposure. Steffan et al. (2005) determined the 
efficacy of Ricobendazole -RBZ against inhibited larvae of Ostertagia ostertagi 
(L4i) at very low for doses of 3.5 and 5.0 mg/kg. However, the drug was highly 
effective at a dose of 7.5 mg/kg confirming the dose-dependence of BIZ deriva-
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tives against trichostrongylideos inhibited stages of nematodes (Duncan, 1976; 
Stasiuk, 2012). 
Whereas the drug or metabolites in plasma provide direct contact with hema-
tophagous species such as Haemonchus contortus and Fasciola hepatica, hel-
minths are closely associated with gut mucosal epithelium encounter metaboli-
tes in digesta as well as those recycling between blood and gut lumen (Hennes-
sy, 1991). On the other hand, FBZ increases the bioavailability of albendazole 
sulphoxide (ABZSO) and this may potentiate anthelmintic action (Merino et al., 
1999; Hunter et al., 2007). 
The following mechanism may explain the wide spectrum and activity on di-
verse stages of parasites (adults, larvae, eggs) of BIZ. The contractile process 
plays a major role in maintenance of life. These processes depend on the con-
traction of specialized proteins that appear very similar through animal species. 
In plathelminths and nematodes, the protein tubulin forms microtubules that are 
essential for transporting low molecular weight substances that parasites incor-
porate as food (Fetterer, 1986; Bennet, 2012). Tubulin also forms systems thro-
ugh which parasite cell secretions are transported. BIZ-C bind tubulin by their 
carbamate group, avoiding its polymerization (Aleyasin, 2015), and interfering 
microtubule function; this is called the colchicino-like effect (Murdry et al., 
1987; Schmit, 2013). This property would suggest that these drugs are mitotic 
toxins, the difference, however, is that colchicine binds tubulin irreversibly, 
whereas BIZ-C binds reversibly to both parasite tubulin and mammalian tubulin 
(Hennessy et al., 1985). This would interfere with normal embryo development 
of nematodes and trematodes (Coles, Briscoe, 1978). 
Despite the structural differences between the external surface of nematodes 
(the cuticle) and the external surface of cestodes and trematodes (the tegument), 
the mechanism of drug entrance into both types of helminth depends on the 
lipophilicity of the anthelmintic and this is the major physicochemical determi-
nant for the drug to reach a therapeutic concentration in the target parasite 
(Alvarez et al., 2007). 
In nematodes, microtubules of absorbent intestinal cells are altered within 
24 h of treatment (Armour, 1986). In cestodes, the tegument is autolysed becau-
se of lack of transportation of lytic enzymes usually secreted to the media (Ro-
berson, 1982). 
In trematodes, BIZ-C with fasciolicidal action do not interfere with energy 
production but their mechanism is still unclear (Fetterer, 1984). MBZ, is active 
against cestodes and nematodes like FBZ (Lassegue et al., 1984), both may only 
interfere with parasite energy metabolism (glucose uptake from the media). 
ABZ has little effect on energy production in in vivo studies with F. he-
patica (Fetterer, 1984). This indicates that FR inhibition would not be im-
portant. Fetterer (1986) suggested inhibition of microtubules function would ex-
plain the letal effect on F. hepatica but did not exclude an additional mode of 
action. 
The sulphoxide metabolite of ABZ induces in vitro surface and internal tegu-
mental changes in Fasciola hepatica (Buchanan, 2003). BIZ-C used exclusively 
in trematodes, triBZ, neither binds tubulin, nor prevents development of embry-
os (Fetterer, 1986), although it is fasciolicydal against mature and immature flu-
ke (Richards et al., 1985). There is possible, therefore, that another process in 
trematodes could be affected by triBZ and other fasciolicydal BIZ-C. 
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1.2. N i t r o i m i d a z o l e s (NIZ) 
Benznidazole is an antitrypanosomic agent, used to treat Chagas disease. 
Trypanosoma cruzi converts this drug to active metabolites, which bind cova-
lently with nuclear material and kinetoplast-DNA of the parasite (Diaz de To-
ranzo, 1987), inhibiting DNA synthesis and energy metabolism by degrading 
polysomes. Early activation of the cellular compartment of the immune system 
by interleukin 12 may favour in vivo benznidazole activity against T. cruzi 
(Michailowsky et al., 1998). A few small observational and randomized studies 
involving patients with chronic Chagas' disease have shown that benznidazole 
reduces the circulating parasite load, enhances seroconversion, and may halt the 
progression of cardiomyopathy (Villar, 2002; Viotti, 2006; Fabbro, 2007). 
Metronidazole and dimetridazole were used in bovine trichomoniasis, and 
also in giardiasis, amoebiasis and balantidiasis in small animals and primates 
(Roberson, 1982). They are now used to treat protozoal and anaerobic bacterial 
infections (Waxman, 2004). Tinidazole has been used in equine giardiasis 
(Elsheihka, Khan, 2011), and a mechanism of action at a ribosomal level has 
been suggested. This effect could be secondary, as the primary mechanism in-
volves inhibition of DNA replication. With metronidazole it seems that DNA 
replication is inhibited rapidly in anaerobic bacteria, though protein synthesis 
continues (Sigeti et al., 1983). Reduction of the nitro group by bacteria or proto-
zoa is necessary to activate the drug (Yeung et al., 1984). Producing toxic meta-
bolites cause DNA strand breakage (Lamp et al., 1999). It should be noted that 
tinidazole displays much higher mutagenic activity than metronidazole in Sal-
monella spp. (Riviere, Papich, 2013). 
1.3. I m i d a z o l e c o m p l e x p h e n o l i c d e r i v a t i v e s 
Miconazole, clotrimazole, ketoconazole and similar drugs are active in su-
perficial and systemic mycosis. Their mechanism of action involves alteration 
of ergosterol synthesis because of inhibition of acetate incorporation. Ketocona-
zole may also inhibit P-glycoprotein (Finch, Pillans, 2014). Consequences are 
increased plasmalemmal thickness, and inhibition of nutrient uptake. TBZ has 
some antimitotic properties also, but its mechanism probably involves inhibition 
of transamination and incorporation of aminoacids into proteins. 
1.4. I m i d a z o t i a z o l e s and d e r i v a t i v e s 
Levamisole had a great impact initially because of its anthelmintic efficacy 
(Chagas et al., 2016) and more recently because of its immunomodulatory acti-
vity (Sanda, 2008; Chagas et al., 2016) that is shared, although slightly, by TBZ 
(Shen, 1981). Its activity over nematodes can be produced by two mechanisms. 
The less important involves, mitochondrial FR inhibition (Rew, 1978; Webster, 
1986) and is attributed to a metabolite lacking sulphur, that blocks sulfhydrile 
enzyme groups, interfering with ATP synthesis (Ruckebusch, 1981; Martin et 
al., 2005). Surprisingly, Shen (1981) suggests the immunomodulatory activity is 
due to a sulphurated metabolite. A second mechanism (Armour, 1986) involves 
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a sustained nicotine-type overstimulation of ganglia, which can be blocked by 
mecamilamine (Roberson, 1982). This induces spastic paralysis of nematodes 
(Taylor et al., 2016). Slight inhibition of acetylcholinesterase is also mentioned, 
and it acts as a cholinergic agonist in T. spiralis (Gimenez Gonzalez et al., 
1998). Mammalian toxicity is produced by a similar mechanism. 
2. SALYCILANILIDES 
2.1. C l o s a n t e l 
Closantel is a wide spectrum, salycilanide endo-ecto-parasiticide, with abili-
ty to uncouple «in vitro» and «in vivo» mitochondrial oxidative phosphoryla-
tion. This results in reduced ATP synthesis with consequent reduction in nut-
rient transport, macromolecular transport and parasite motility (van der Lugt, 
Venter, 2007). 
Some investigations demonstrated closantel had anticholinesterase characte-
ristics, which would explain its ectoparasiticide activity (Brem, Roux, 1984). 
However, administration of 5 mg/kg to cattle did not produce ectoparasiticidal 
action, although cholinesterase was reduced by 78 % (Brem, Roux, 1984). Thus 
anticholinesterase activity is not the most important effect. 
As salicylanilide drugs have high membrane activity, a precise definition 
of its mechanism of action is not yet possible but future research should clarity 
this. 
Rajamuthiah et al. (2014) confirmed that of closantel has an anti-staphylo-
coccal activity against vancomycin-resistant S. aureus isolates and other Gram-
positive bacteria. 
2.2. D i a m p h e n e t i d e 
This drug is extremely effective against juvenile flukes, but first needs to be 
converted to an active trematodicidal metabolite in the host (Rew et al., 1983). 
This deacetylated metabolite causes severe morphological damage (erosion of 
the tegument, and breakage of the tegumental osmoregulatory system, blocking 
of normal development sequence of vitelline cells) to the fluke. Diamphenetide 
blocks the protein synthesis of the parasite (Naranjo Feliciano, 2009). It does 
not appear to act on energy metabolism, but may be a potent Na+/K+/ATPase 
inhibitor. It also induces a rapid spastic (Rew et al., 1983) or flaccid (Fairwe-
ather et al., 1984) paralysis. 
3. TETRAHYDROPYRIMIDINES: PYRANTEL 
AND MORANTEL 
Studies on the mechanism of action of tetrahydropyrimidines indicate they 
are similar to levamisole (Andrews, 2004). They act as cholinergic receptor 
agonists in nematodes (Köhler, 2001), with effects 100 times more potent than 
acetylcholine (ACH) and not so easily reversible, depending on drug concentra-
tion (Terada et al., 1983a). Other author suggested that pyrantel was a nicotinic 
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agonist in Ascaris spp. inducing a spastic paralysis because of persistent gang-
lionar stimulation (Yan, 2009). Terada et al. (1983b) confirmed this hypothesis 
working with another nematode, Angiostrongilus cantonensis. 
4. ETILENDIAMINES: PIPERAZINE 
Piperazine is a cheap and readily available anthelmintic agent with very wide 
therapeutic index (Ghasi et al., 2009). It produces an opposite effect to that of 
morantel, pyrantel and avermectin (Terada et al., 1983b). Pyrantel would be an-
tagonized by drugs that mimic or stimulate liberation of inhibitory neurotrans-
miters namely a-adrenergics, and gamma-Aminobutyric acid -GABAergics in 
mammals. The toxicity could also be due to nicotinic stimulation at a ganglion 
and neuromuscular junction levels (Terada et al., 1983a). Z350, a synthesized 
piperazine derivative, posses a-1-adrenoceptor agonic effects and it is also a ste-
roid 5-a-reductase inhibitor (Fukuda et al., 1999). A series of imidazo (1,5-a) 
quinoxaline piperazine ureas alert-butyl ester side chain at the 3 position all 
have high affinity for the GABA/benzodiazepine receptor complex an effects 
ranging from inverse agonists to full agonists. Additionally, several analogues 
were also effective normalising ciclic guanosin mono phosphate (cGMP) levels 
after applied stress, also consistent with anxyolytic-like properties (Jacobsen 
et al., 1999). It was therefore suggested that piperazine could have a quinidi-
ne-like action, and therefore could possess antiarrhythmic properties (Ghasi, 
2009). 
5. FORMAMIDINES: AMITRAZ 
The acaricidal and inseticidal activity of amitraz (AMZ) is due to its ant-
agonistic effect on octopamine receptors of the nerve cells in the brain. Parasites 
become hyperexcited, paralyzed and eventually die. This mode of action is dif-
ferent from those of synthetic pyrethroids, organophosphates and other ectopa-
rasiticides (Junquera, 2015). AMZ actions against ectoparasites can be either 
pestistatic (sub-lethal) and pesticidal (lethal) depending on the drug concentra-
tion (Giordani et al., 1986). The lethal action develops with extreme excitability, 
incoordination and death. These actions can be explained by its interaction with 
octopaminegic receptors in affected mites and ticks. Several decades of research 
support the hypothesis that different isoforms of OPM receptors are localized 
pre- and postsynaptically, so OPM may act at a peripheral level, by modulating 
muscular excitability pre- or post-synaptically, depending on the invertebrate 
species. OPM presence has been demonstrated in the central ganglion of lobs-
ters and some other invertebrates and in the synganglion of ticks (Morton, 1983; 
Morton, Evans, 1983, 1984). In some of these animals OPM activity is mediated 
through an OPM dependent adenylcyclase. It is common in insects octopami-
nergic systems for OPM to be blocked by phentolamine (an a-adrenergic bloc-
ker) and not by propranolol (a ß-adrenergic blocker) (Evans, 1981; Vehovszky, 
2000). Formamidines thus act at two levels as octopaminergic agonists (Essam, 
2001), probably producing abnormal responses by a central action (Murdock, 
Hollingworth, 1980) and the nervous hyperexcitability through central and/or 
peripheral effect. Its effect is lethal because its binding to OPM receptors is 
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much more persistent than for OPM itself. Jorens et al. (1997) described AMZ 
as an a-2-adrenergic agonist. 
The AMZ metabolite n-2, 4-demethylphenylmethylformamidine is more po-
tent than AMZ in mites (Morton, 1983) and also in ticks (Schunter, Thompson, 
1978). 
Prostaglandins have long been associated with a negative effects on meta-
bolism of intestinal helminths but, on the other hand, they are also involved 
in tick feeding. This suggests that activity of formamidines in general, and of 
AMZ in particular, could be, at least partly by inhibition of prostaglanding 
synthesis (Bonsall, Turnbull, 1983). 
6. PRAZIQUANTEL 
A major characteristic of this drug is its efficacy against cestodes, including 
those with low susceptibility, like Echinococcus spp. and Diphylidium caninum 
(Chai, 2013). Praziquantel is used as a trematodicide in people and is also effec-
tive against trematodes of veterinary importance (Armour, 1986; Chai, 2013). 
Its antiparasitic effect is a consequence of two actions. One of these produ-
ces sustained, violent muscle contractions resulting in spastic paralysis of the 
parasite (Maule, 2005) and release from the attachment point. In humans, mig-
ration from mesenteric veins to the liver was reported. This action is produced 
by increased parasite membrane permeability to mono- and di-valent cations, 
specially Ca++ (Kohn, 2003; Maule, 2005; Jeziorskia, 2006). Although the rapid 
and intense contraction of the parasite is attributed to an action on ATPases 
responsible for calcium homeostasis. Praziquantel concentrations as high as 
100 p,M did not inhibit Na/K ATPase from tegument, Ca/Mg ATPase from he-
terogeneous and microsomal fractions of parasites, nor calcium permeability of 
microsomal vesicles (Cunha, Noel, 1997). These findings in S. mansoni do not 
support the proposed mechanism of praziquantel-induced contraction. The other 
postulated mechanism is also related to increase Ca++ influx, that leads to tegu-
ment vacuolisation and vesiculisation and kills the parasite. There is probably 
some relation between both mechanisms, as paralysis is an ion dependent effect 
(Bricker et al., 1983). 
Doubts have been expressed as to whether it is the parent drug, or a metabo-
lite (Roberson, 1982), that is responsible for the drug's actions. Praziquantel is 
rapidly taken up but not metabolized by parasites, although is metabolized by 
host mammals (Jeziorskia, 2006). 
In Schistosoma spp. praziquantel does not affect immature stages (Matsuda 
et al., 1983) but favours mature eggs incubation. It has some activity on imma-
ture cestodes but lacks effect on hydatid cysts (Roberson, 1982). 
7. PHENOLS 
Hexylresorcinol (HR) was used in the past against Ascaris spp. and Ancylos-
tome spp. in dogs and Ascaris spp. and Oxyurus spp. in humans (Lores Arnaiz 
et al., 1976), but has been replaced by better tolerated and more efficacious 
drugs (Krupyanski, 2012). 
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The mechanism of action was described as involving formation of tegument 
vesicles that evolved into more complicated lesions that killed the parasite. 
However, later articles described a more selective mechanism. Flaccid paralysis 
was found in A. cantonensis, D. immitis and A. caninum, before any tegument 
lesion occurred (Terada et al., 1985). However, the paralyzed parasites contrac-
ted in response to pyrantel, a nicotinic agonist. The paralysis was not antagoni-
zed by GABA or a-adrenergic blockers. Thus, HR may impede ACH liberation 
from cholinergic nerves, an effect that would be augmented by drugs like pipe-
razine and ivermectin. This hypothesis requires experimental confirmation. It 
has been demonstrated that HR produces a inhibition of lysozyme activity 
which occurs at hexylresorcinol concentrations lower by an order of magnitude 
than glycerol inhibiting concentrations (Krupyanskii et al., 2012). 
Disophenol, niclosamide and dichlorophen, which are structurally related to 
HR, could act by a similar mechanism. Phenols are sufficiently membrane acti-
ve drugs, to make clear definition of their mechanisms of action difficult; there 
are probably other factors involved as well. 
8. ORGANOPHOSPHATES 
Organophosphates (OPs) compounds are the organic derivatives of phospho-
rous containing acids and their effect on neuromuscular junction and autonomic 
synapses is clinically important (Azazh, 2011). They are wide spectrum drugs 
that act by interfering with NT of the cholinergic system. They have has been 
used as internal and external antiparasitic drugs. Among those used to treat ecto-
parasitosis are propetamphos and diazinon. Dichlorvos and metriophonate (tri-
chlorphon) are the only compounds used today to treat adult gastrointestinal pa-
rasites and S. mansoni. 
OPs act by blocking AChase hydrolysis in sites of cholinergic activity (Cha-
tonnet et al., 1999; Bajgar, 2004). It was suggested that as in mammals, AChase 
has two binding sites: an anionic site, formed by an ionized carboxylic group 
that binds to the cationic AChase site complemented by van der Waals forces, 
and an estearic site, that binds the portion of AChase corresponding to acetic 
acid (Wilson, 1967; Bajgar, 2004). 
Once the substrate has bound reversibly to the enzyme, hydrolysis takes pla-
ce in two steps: First, choline is liberated leaving the enzyme acetylated, and 
then acetic acid is liberated and enzyme regenerated. OPS only react with the 
esteratic cholinesterase site, producing a stable and irreversible union (Elersek, 
Filipic, 2011). The under graded AChase accumulates eliciting excitability in 
cholinergic synapses in ganglia, parasympathetic terminals, neuromuscular jun-
ctions and CNS (Burgat-Sacaze et al., 1988). Degradation of the enzyme can be 
achieved with the combination of AChase and oximes (Gordon et al., 1999). 
Arthropods are much more sensitive than mammals to OPs, and differences 
in sensitivity among different acetylcholinesterases, together with pharmacoki-
netic characteristics, like penetration into the parasite, could explain the various 
degrees of resistance found in arthropods. 
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9. PYRETHRINS AND PYRETHROIDS 
Natural pyrethroids (pyrethrins, cinnerins and jasmolins) were obtained from 
Crisanthemum cinerariaefolium flowers. Because of the ester bond that charac-
terizes their structure, natural pyrethrins are easily degraded by environmental 
factors (light, oxygen and alkalis) or by enzymatic systems of mammals and in-
sects. Because of that the value of natural pyrethrins against insects is limited 
(Metcalf, 2002). 
Synthetic pyrethrins or pyrethroids were developed to increase the potency 
and width of antiparasitic activity. They can be classified into type I (allethrin, 
tetramethrin, phenothrin, resmethrin, permethrin), and type II (cypermethrin, 
flumethrin, cyalothrin, cypothrin) agents. Type II pyrethroids includes a cyano 
group which increases spectrum and stability. 
Pyrethroids' antiparasitic activity involves alteration of CNS function by 
means of changes in ionic conductance through neuronal membranes (Cagen et 
al., 1984; Soderlund, 2002). This activity can be mediated through three mecha-
nisms. Firstly, interaction with one or more portions of the GABA receptor le-
ads to synaptic activity (Doherty et al., 1988). GABA inhibits transmission in 
normal situations, permitting neurones rest (Giordani et al., 1989). This is to ac-
complished through it opening of Cl- channels and consequent Cl- influx and 
membrane hyperpolarization (Giordani et al., 1987). Type II pyrethroids binds 
to the GABA receptor at the Cl- channel level, acting as GABA agonists and 
producing hyperexcitability and paralysis (Taylor-Wells et al., 2015). Secondly, 
both classes of pyrethroids interact with nicotinic receptors by binding to ionic 
channels, depending on the nicotinc ACH receptor, thus altering the ionic flow 
and inhibiting paralysing the in insects or host. 
The third mechanism of action would be mediated through reversible and 
stereospecific binding to receptors in axonal Na+ channels, specially a-subunits 
(Dong et al., 2014). This would retard closing of the channels, with increased 
Na+ influx, eliciting repetitive discharges, hyperexcitability and paralysis, espe-
cially with type I pyrethroids. For type II agents the process is much slower, gi-
ving rise to depolarization and consequent paralysis (Gotoh et al., 1998). Rao 
and Rao (1997) found permethrin and cypermethrin decreased K+ uptake across 
synaptosomes in rat brain. In other way, permethrin and resmethrin consistently 
stimulated ATP-dependent and ATP-independent uptake of glutamate, without 
evoking depletion of its vesicular content (Vaccari et al., 1998). 
10. ORGANOCHLORINES: 
DICHLORODIPHENYLTRICHLOROETHANE (DDT) 
The efficacy of these drugs against insects and mites and their mammalian 
toxicity are well known. The mode of action differ between various agents in 
the group. 
DDT can act by contact or by ingestion because of its high liposolubility. 
It acts as described for type 1 pyrethroids in invertebrates (Lund, 1984) and 
vertebrates (Herr et al., 1986), altering channels that regulated Na+ permea-
bility though membranes causing increased excitability (Denholm et al., 
2002). 
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Only a small change in the channels is required to elicit this effect. In verteb-
rates, tremors affect head and neck first and progress caudally probably causing 
paralysis, depending on drug concentration and exposure time (Herr et al., 
1986). 
Cross-resistance had been demonstrated between DDT and pyrethroids in 
various insects and mites (Nardini et al., 2013). The lethality of DDT is known 
to correlate with its content in brain. The similarity of the signs of toxicosis with 
DDT and type I pyrethroids suggests they have a similar mode of action resul-
ting from specific interactions with either GABA or glutamate receptor/iono-
phore complexes (Doherty et al., 1988). 
11. CYCLODIENES: ALDRIN, DIELDRIN, LINDANE 
11a. Aldrin and Dieldrin are too toxic to be used safely in animals (U. S. De-
partment of Health and Human Services, 2002). They are included here only as 
a reference for a better understanding of lindane. They are powerful CNS stimu-
lants in vertebrates and invertebrtates. This action is due to GABA antagonism 
(Matsumura, 1984). 
In mammals, these agents tends to elicit convulsions, even without prodro-
mic signs (Klaassen, 1986). They bind to the picrotoxin (PT) site of the GABA 
receptor. The degree of binding is well correlated with insecticidal action (Mat-
sumura, 1984). Resistant insects have changes in the spatial structure of the re-
ceptor and either do not bind these drugs or bind them in very low amounts. In 
other cases the number of receptors diminishes (Matsumura, 1984). 
11b. Lindane also binds to this same site in mammals namely the complex 
GABA-benzodiazepines receptor in the zone corresponding to the chlorine 
ionophore (Benarroch, 2006). This zone binds PT and other convulsant drugs 
the PT-like convulsants. A potent convulsant, 35-S butylbicyclophosphotionate 
(TBPS) binds to another site of the ionophore, a site that it shares with lindane 
in rat CNS (Eldefrawi et al., 1984). This apparent discrepancy in lindane bin-
ding sites, is not important, because the sites are adjacent, and the mechanism 
leading to convulsions is the same in either case involving failure of chlorine 
ionophores to open, lack of chlorine entry, hyperexcitability and convulsions. 
A similar mechanism of action probably exists in insects and mites. 
The lack of cross resistance between DDT and lindane would be because the 
drugs act at different sites. 
12. AVERMECTINS AND MILBEMICINS 
Avermectins (AVM) and milbemycins (MBC) are macrocyclic lactones de-
rived from Streptomyces avermitilis and S. syanogriceous mycelia respectively 
(Lumaret et al., 2012). They all are regarded as wide spectrum antiparasitic 
drugs (Campbell, 1989). 
These drugs seem to have similar mechanisms of action, though the mecha-
nisms are not yet completely clear. Activity on GABA receptors has been de-
monstrated, particularly in mammals, but the process seems very complex 
(Mendes, 2017). Various theories have been expounded: 
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1. GABAergic agonism. Ivermectin would bind to GABA receptors exerting 
a GABA-like action (Estrada-Mondragon, Lynch, 2015). 
2. Potentiation of GABA-receptor binding (Campbell et al., 1983; Menez et 
al., 2012). 
3. Stimulation of presynaptic liberation of GABA. This would be similar to 
other mechanisms reported in mammalian synaptosomes through which GABA 
would be liberated from presynaptic endings (Giordani et al., 1988). 
4. Increase in the number of GABA receptors (Giordani et al., 1988; Camp-
bell et al., 1993). 
5. Stimulation of adrenergic and/or GABAergic, or inhibition of cholinergic 
mechanisms (Terada et al., 1984). The adrenergic mechanism could be similar 
to that in mammals, in which GABAeregic neurones' receptors liberate GABA 
when stimulated by noradrenalin (Giordani et al., 1988; Campbell et al., 1993). 
6. Increased Cl- permeability in muscles (Mehlhorn, Aspock, 2008). Musc-
les in lobsters (Schistocerca gregaria) exposed to B1a dihydroavermectin 
shown reversible and irreversible increases in Cl- permeability. This could be 
caused by: 
A. Changes in lipids or other membrane components (Haydon et al., 1977). 
B. «in vitro» changes in GABA receptor selectivity by diverse anions (Cl-, 
Br+, I ) (Scott et al., 1985). 
C. Interaction with glutamate receptors (receptor H), that could hyperpola-
rize muscle membranes by opening Cl- channels (Scott et al., 1985). Other 
authors, however, reported glutamate as an excitatory neurotransmitter (Usher-
wood, 1984). 
D. Modification of chlorine channels not necessarily related to GABA recep-
tors (Smart, 1982). 
Binding to parasitic retinol binding protein (PRBP) (Sani et al., 1988; Garo-
falo, 2002). PRBP binds retinol at the cell surface and the resulting complex 
migrates through cytoplasm to the nucleus, where has a specific effect on gene 
expression (Sani et al., 1983). The role of retinoids in helminths is not complete-
ly clear, but it could be involved in vital biological functions as in mammals, 
like growth and reproduction. IVM which has structural similarities to retinol 
inhibits binding of (3H) retinol to PRBP in very low concentrations (Sani, 
1984). Reproductive alterations in parasites could be due to this mechanism 
instead of GABAergic interaction (Giordani et al., 1988). 
All except the last theory involve blockage in postsynaptic transmission by 
interrupting Cl- influx entrance; the Cl- hyperpolarizes cell membranes, so sti-
muli cannot pass. 
Another theory about the mechanism of action could explain the toxicity in 
different animals. In normal tissues, P-glycoprotein, is found on the luminal sur-
face of cells of renal proximal tubules, small intestine and colon, and bile cana-
licular face of hepatocytes, as well as in adrenal glands and capillary endothelial 
cells in brain and testes. P-glycoprotein plays an important role in absorption 
and distribution of many chemotherapeutic agents across the blood-brain barrier 
(Didier, Loor, 1995; Benet, 2009). 
Lankas et al. (1997) studied a subpopulation of CF-1 mice that showed mar-
ked susceptibility to avermectins and lack P-glycoprotein. When IVM was in-
jected into these mice, very high tissue ivermectin concentrations were found, 
especially in brain. By comparison, CD-1 mice with high P-glycoprotein levels 
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were relatively resistent to ivermectin toxicosis and tolerated doses more than 
50 times greater than the minimum toxic dose for P-glycoprotein deficien mice. 
When pregnant female CF-1 mice were given ivermectin (Lankas et al., 1998), 
homozygous P-glycoprotein deficient foetuses all suffered cleft palates, where-
as heterozygous littermates were less susceptible, and homozygous P-glycopro-
tein replete fetuses were unaffected at all doses tested. 
The idea that ivermectin was safe for mammalian treatment because of its 
very complex structure and difficulty in crossing the blood-brain barrier where 
most GABA inhibitor neurotransmitters act, was re-examined. When conside-
ring the use of macrocyclic lactones dogs, veterinarians may take into account 
the known sensitivity of Scotch collies (both rough and smooth) to neurotoxicity 
when administered these drugs at higher than label doses. But the adage has also 
been applied to many other herding breeds and has prevented veterinarians from 
using these drugs in situations where they would have been ideal. The neuroto-
xicity was attributed to a leaky «blood-brain barrier» in susceptible dogs. De-
velopments in the molecular mechanisms of this phenomenon have opened a 
new frontier in the area of pharmacogenetics, drug disposition determined by 
the animal's genotype. Genetic studies have documented the mdr gene deletion 
in 10 breeds. Dogs that are homozygous for the gene deletion readily show ad-
verse effects from ivermectin and other P-glycoprotein substrate drugs at dosa-
ges that cause no adverse effects in normal dogs. Heterozygote dogs may show 
toxicity at increased doses of substrate drugs, such as daily ivermectin administ-
ration for the treatment of demodecosis (Dowling, 2006). 
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